Drug project high-priority medications: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Gerald Chi (talk | contribs) mNo edit summary |
||
Line 8: | Line 8: | ||
<div style="float: left; padding: .5ex 0; font-weight: bold; background-color: #CEDFF2; border: 2px solid #999; border-bottom: 0; border-left: 0; font-size: 90%"> [[Drug project high-priority medications|High-Priority Medications]] </div> | <div style="float: left; padding: .5ex 0; font-weight: bold; background-color: #CEDFF2; border: 2px solid #999; border-bottom: 0; border-left: 0; font-size: 90%"> [[Drug project high-priority medications|High-Priority Medications]] </div> | ||
</div> | </div> | ||
<div style="clear:both; width: 95%; border: 3px solid #999; padding: 1em 1em | <div style="clear:both; width: 95%; border: 3px solid #999; padding: 1em 1em;"> | ||
==WikiDoc Drug Project — High-Priority Medications== | ==WikiDoc Drug Project — High-Priority Medications== | ||
Line 16: | Line 16: | ||
====List of high-priority medications==== | ====List of high-priority medications==== | ||
{| class="wikitable" | |||
| align="center" style="background:#f0f0f0;"|'''Year''' | |||
| align="center" style="background:#f0f0f0;"|'''No.''' | |||
| align="center" style="background:#f0f0f0;"|'''Brand Name''' | |||
| align="center" style="background:#f0f0f0;"|'''Active Ingredient''' | |||
| align="center" style="background:#f0f0f0;"|'''Page Link''' | |||
| align="center" style="background:#f0f0f0;"|'''DailyMed Search''' | |||
| align="center" style="background:#f0f0f0;"|'''Approval Date''' | |||
|- | |||
| 2019||12||Polivy||Polatuzumab vedotin-piiq||[[Polatuzumab vedotin-piiq]]||Polatuzumab vedotin-piiq||6/10/2019 | |||
|- | |||
| 2019||11||Piqray||Alpelisib||[[Alpelisib]]||Alpelisib||5/24/2019 | |||
|- | |||
| 2019||10||Vyndaqel||Tafamidis meglumine||[[Tafamidis meglumine]]||Tafamidis meglumine||5/3/2019 | |||
|- | |||
| 2019||9||Skyrizi||Risankizumab-rzaa||[[Risankizumab-rzaa]]||Risankizumab-rzaa||4/23/2019 | |||
|- | |||
| 2019||8||Balversa||Erdafitinib||[[Erdafitinib]]||Erdafitinib||4/12/2019 | |||
|- | |||
| 2019||7||Evenity||Romosozumab-aqqg||[[Romosozumab-aqqg]]||Romosozumab-aqqg||4/9/2019 | |||
|- | |||
| 2019||6||Mayzent||Siponimod||[[Siponimod]]||Siponimod||3/26/2019 | |||
|- | |||
| 2019||5||Sunosi||Solriamfetol||[[Solriamfetol]]||Solriamfetol||3/20/2019 | |||
|- | |||
| 2019||4||Zulresso||Brexanolone||[[Brexanolone]]||Brexanolone||3/19/2019 | |||
|- | |||
| 2019||3||Egaten||Triclabendazole||[[Triclabendazole]]||Triclabendazole||2/13/2019 | |||
|- | |||
| 2019||2||Cablivi||Caplacizumab-yhdp||[[Caplacizumab-yhdp]]||Caplacizumab-yhdp||2/6/2019 | |||
|- | |||
| 2019||1||Jeuveau||Prabotulinumtoxina-xvfs||[[Prabotulinumtoxina-xvfs]]||Prabotulinumtoxina-xvfs||2/1/2019 | |||
|- | |||
| 2018||59||Ultomiris||Ravulizumab||[[Ravulizumab]]||Ravulizumab||12/21/2018 | |||
|- | |||
| 2018||58||Elzonris||Tagraxofusp-erzs||[[Tagraxofusp-erzs]]||Tagraxofusp-erzs||12/21/2018 | |||
|- | |||
| 2018||57||Asparlas||Calaspargase pegol-mknl||[[Calaspargase pegol-mknl]]||Calaspargase pegol-mknl||12/20/2018 | |||
|- | |||
| 2018||56||Motegrity||Prucalopride||[[Prucalopride]]||Prucalopride||12/14/2018 | |||
|- | |||
| 2018||55||Xospata||Gilteritinib||[[Gilteritinib]]||Gilteritinib||11/28/2018 | |||
|- | |||
| 2018||54||Firdapse||Amifampridine||[[Amifampridine]]||Amifampridine||11/28/2028 | |||
|- | |||
| 2018||53||Vitrakvi||Larotrectinib||[[Larotrectinib]]||Larotrectinib||11/26/2018 | |||
|- | |||
| 2018||52||Daurismo||Glasdegib||[[Glasdegib]]||Glasdegib||11/21/2018 | |||
|- | |||
| 2018||51||Gamifant||Emapalumab-lzsgemapalumab-lzsg||[[Emapalumab-lzsgemapalumab-lzsg]]||Emapalumab-lzsgemapalumab-lzsg||11/20/2018 | |||
|- | |||
| 2018||50||Aemcolo||Rifamycin||[[Rifamycin]]||Rifamycin||11/16/2018 | |||
|- | |||
| 2018||49||Yupelri||Revefenacin||[[Revefenacin]]||Revefenacin||11/9/2018 | |||
|- | |||
| 2018||48||Lorbrena||Lorlatinib||[[Lorlatinib]]||Lorlatinib||11/2/2018 | |||
|- | |||
| 2018||47||Xofluza||Baloxavir marboxil||[[Baloxavir marboxil]]||Baloxavir marboxil||10/24/2018 | |||
|- | |||
| 2018||46||Talzenna||Talazoparib||[[Talazoparib]]||Talazoparib||10/16/2018 | |||
|- | |||
| 2018||45||Tegsedi||Inotersen||[[Inotersen]]||Inotersen||10/5/2018 | |||
|- | |||
| 2018||44||Revcovi||Elapegademase-lvlr||[[Elapegademase-lvlr]]||Elapegademase-lvlr||10/5/2018 | |||
|- | |||
| 2018||43||Nuzyra||Omadacycline||[[Omadacycline]]||Omadacycline||10/2/2018 | |||
|- | |||
| 2018||42||Seysara||Sarecycline||[[Sarecycline]]||Sarecycline||10/1/2018 | |||
|- | |||
| 2018||41||Libtayo||Cemiplimab-rwlc||[[Cemiplimab-rwlc]]||Cemiplimab-rwlc||9/28/2018 | |||
|- | |||
| 2018||40||Vizimpro||Dacomitinib||[[Dacomitinib]]||Dacomitinib||9/27/2018 | |||
|- | |||
| 2018||39||Emgality||Galcanezumab-gnlm||[[Galcanezumab-gnlm]]||Galcanezumab-gnlm||9/27/2018 | |||
|- | |||
| 2018||38||Copiktra||Duvelisib||[[Duvelisib]]||Duvelisib||9/24/2018 | |||
|- | |||
| 2018||37||Ajovy||Fremanezumab-vfrm||[[Fremanezumab-vfrm]]||Fremanezumab-vfrm||9/14/2018 | |||
|- | |||
| 2018||36||Lumoxiti||Moxetumomab pasudotox-tdfk||[[Moxetumomab pasudotox-tdfk]]||Moxetumomab pasudotox-tdfk||9/13/2018 | |||
|- | |||
| 2018||35||Pifeltro||Doravirine||[[Doravirine]]||Doravirine||8/30/2018 | |||
|- | |||
| 2018||34||Xerava||Eravacycline||[[Eravacycline]]||Eravacycline||8/27/2018 | |||
|- | |||
| 2018||33||Takhzyro||Lanadelumab||[[Lanadelumab]]||Lanadelumab||8/23/2018 | |||
|- | |||
| 2018||32||Oxervate||Cenegermin-bkbj||[[Cenegermin-bkbj]]||Cenegermin-bkbj||8/22/2018 | |||
|- | |||
| 2018||31||Diacomit||Stiripentol||[[Stiripentol]]||Stiripentol||8/20/2018 | |||
|- | |||
| 2018||30||Galafold||Migalastat||[[Migalastat]]||Migalastat||8/10/2018 | |||
|- | |||
| 2018||29||Annovera||Segesterone acetate and ethinyl estradiol vaginal system||[[Segesterone acetate and ethinyl estradiol vaginal system]]||Segesterone acetate and ethinyl estradiol vaginal system||8/10/2018 | |||
|- | |||
| 2018||28||Onpattro||Patisiran||[[Patisiran]]||Patisiran||8/10/2018 | |||
|- | |||
| 2018||27||Poteligeo||Mogamulizumab-kpkc||[[Mogamulizumab-kpkc]]||Mogamulizumab-kpkc||8/8/2018 | |||
|- | |||
| 2018||26||Mulpleta||Lusutrombopag||[[Lusutrombopag]]||Lusutrombopag||7/31/2018 | |||
|- | |||
| 2018||25||Omegaven||Fish oil triglycerides||[[Fish oil triglycerides]]||Fish oil triglycerides||7/27/2018 | |||
|- | |||
| 2018||24||Orilissa||Elagolix sodium||[[Elagolix sodium]]||Elagolix sodium||7/23/2018 | |||
|- | |||
| 2018||23||Krintafel||Tafenoquine||[[Tafenoquine]]||Tafenoquine||7/20/2018 | |||
|- | |||
| 2018||22||Tibsovo||Ivosidenib||[[Ivosidenib]]||Ivosidenib||7/20/2018 | |||
|- | |||
| 2018||21||TPOXX||Tecovirimat||[[Tecovirimat]]||Tecovirimat||7/13/2018 | |||
|- | |||
| 2018||20||Braftovi||Encorafenib||[[Encorafenib]]||Encorafenib||6/27/2018 | |||
|- | |||
| 2018||19||Mektovi||Binimetinib||[[Binimetinib]]||Binimetinib||6/27/2018 | |||
|- | |||
| 2018||18||Zemdri||Plazomicin||[[Plazomicin]]||Plazomicin||6/25/2018 | |||
|- | |||
| 2018||17||Epidioloex||Cannabidiol||[[Cannabidiol]]||Cannabidiol||6/25/2018 | |||
|- | |||
| 2018||16||Moxidectin||Moxidectin||[[Moxidectin]]||Moxidectin||6/13/2018 | |||
|- | |||
| 2018||15||Olumiant||Baricitinib||[[Baricitinib]]||Baricitinib||5/31/2018 | |||
|- | |||
| 2018||14||Palynziq||Pegvaliase-pqpz||[[Pegvaliase-pqpz]]||Pegvaliase-pqpz||5/24/2018 | |||
|- | |||
| 2018||13||Doptelet||Avatrombopag||[[Avatrombopag]]||Avatrombopag||5/21/2018 | |||
|- | |||
| 2018||12||Lokelma||Sodium zirconium cyclosilicate||[[Sodium zirconium cyclosilicate]]||Sodium zirconium cyclosilicate||5/18/2018 | |||
|- | |||
| 2018||11||Aimovig||Erenumab-aooe||[[Erenumab-aooe]]||Erenumab-aooe||5/17/2018 | |||
|- | |||
| 2018||10||Lucemyra||Lofexidine hydrochloride||[[Lofexidine hydrochloride]]||Lofexidine hydrochloride||5/16/2018 | |||
|- | |||
| 2018||9||Akynzeo||Fosnetupitant and palonosetron||[[Fosnetupitant and palonosetron]]||Fosnetupitant and palonosetron||4/19/2018 | |||
|- | |||
| 2018||8||Crysvita||Burosumab-twza||[[Burosumab-twza]]||Burosumab-twza||4/17/2018 | |||
|- | |||
| 2018||7||Tavalisse||Fostamatinib||[[Fostamatinib]]||Fostamatinib||4/17/2018 | |||
|- | |||
| 2018||6||Ilumya||Tildrakizumab||[[Tildrakizumab]]||Tildrakizumab||3/20/2018 | |||
|- | |||
| 2018||5||Trogarzo||Ibalizumab-uiyk||[[Ibalizumab-uiyk]]||Ibalizumab-uiyk||3/6/2018 | |||
|- | |||
| 2018||4||Erleada||Apalutamide||[[Apalutamide]]||Apalutamide||2/14/2018 | |||
|- | |||
| 2018||3||Symdeko||Tezacaftor; ivacaftor||[[Tezacaftor; ivacaftor]]||Tezacaftor; ivacaftor||2/12/2018 | |||
|- | |||
| 2018||2||Biktarvy||Bictegravir, embitcitabine, tenofovir alafenamide||[[Bictegravir, embitcitabine, tenofovir alafenamide]]||Bictegravir, embitcitabine, tenofovir alafenamide||2/7/2018 | |||
|- | |||
| 2018||1||Lutathera||Lutetium lu 177 dotatate||[[Lutetium lu 177 dotatate]]||Lutetium lu 177 dotatate||1/26/2018 | |||
|} | |||
</div> | </div> |
Revision as of 17:36, 19 June 2019
WikiDoc Drug Project — High-Priority Medications
- Template here: Drug page template
- Example here: Clopidogrel
- FDA package insert here: DailyMed
List of high-priority medications
Year | No. | Brand Name | Active Ingredient | Page Link | DailyMed Search | Approval Date |
2019 | 12 | Polivy | Polatuzumab vedotin-piiq | Polatuzumab vedotin-piiq | Polatuzumab vedotin-piiq | 6/10/2019 |
2019 | 11 | Piqray | Alpelisib | Alpelisib | Alpelisib | 5/24/2019 |
2019 | 10 | Vyndaqel | Tafamidis meglumine | Tafamidis meglumine | Tafamidis meglumine | 5/3/2019 |
2019 | 9 | Skyrizi | Risankizumab-rzaa | Risankizumab-rzaa | Risankizumab-rzaa | 4/23/2019 |
2019 | 8 | Balversa | Erdafitinib | Erdafitinib | Erdafitinib | 4/12/2019 |
2019 | 7 | Evenity | Romosozumab-aqqg | Romosozumab-aqqg | Romosozumab-aqqg | 4/9/2019 |
2019 | 6 | Mayzent | Siponimod | Siponimod | Siponimod | 3/26/2019 |
2019 | 5 | Sunosi | Solriamfetol | Solriamfetol | Solriamfetol | 3/20/2019 |
2019 | 4 | Zulresso | Brexanolone | Brexanolone | Brexanolone | 3/19/2019 |
2019 | 3 | Egaten | Triclabendazole | Triclabendazole | Triclabendazole | 2/13/2019 |
2019 | 2 | Cablivi | Caplacizumab-yhdp | Caplacizumab-yhdp | Caplacizumab-yhdp | 2/6/2019 |
2019 | 1 | Jeuveau | Prabotulinumtoxina-xvfs | Prabotulinumtoxina-xvfs | Prabotulinumtoxina-xvfs | 2/1/2019 |
2018 | 59 | Ultomiris | Ravulizumab | Ravulizumab | Ravulizumab | 12/21/2018 |
2018 | 58 | Elzonris | Tagraxofusp-erzs | Tagraxofusp-erzs | Tagraxofusp-erzs | 12/21/2018 |
2018 | 57 | Asparlas | Calaspargase pegol-mknl | Calaspargase pegol-mknl | Calaspargase pegol-mknl | 12/20/2018 |
2018 | 56 | Motegrity | Prucalopride | Prucalopride | Prucalopride | 12/14/2018 |
2018 | 55 | Xospata | Gilteritinib | Gilteritinib | Gilteritinib | 11/28/2018 |
2018 | 54 | Firdapse | Amifampridine | Amifampridine | Amifampridine | 11/28/2028 |
2018 | 53 | Vitrakvi | Larotrectinib | Larotrectinib | Larotrectinib | 11/26/2018 |
2018 | 52 | Daurismo | Glasdegib | Glasdegib | Glasdegib | 11/21/2018 |
2018 | 51 | Gamifant | Emapalumab-lzsgemapalumab-lzsg | Emapalumab-lzsgemapalumab-lzsg | Emapalumab-lzsgemapalumab-lzsg | 11/20/2018 |
2018 | 50 | Aemcolo | Rifamycin | Rifamycin | Rifamycin | 11/16/2018 |
2018 | 49 | Yupelri | Revefenacin | Revefenacin | Revefenacin | 11/9/2018 |
2018 | 48 | Lorbrena | Lorlatinib | Lorlatinib | Lorlatinib | 11/2/2018 |
2018 | 47 | Xofluza | Baloxavir marboxil | Baloxavir marboxil | Baloxavir marboxil | 10/24/2018 |
2018 | 46 | Talzenna | Talazoparib | Talazoparib | Talazoparib | 10/16/2018 |
2018 | 45 | Tegsedi | Inotersen | Inotersen | Inotersen | 10/5/2018 |
2018 | 44 | Revcovi | Elapegademase-lvlr | Elapegademase-lvlr | Elapegademase-lvlr | 10/5/2018 |
2018 | 43 | Nuzyra | Omadacycline | Omadacycline | Omadacycline | 10/2/2018 |
2018 | 42 | Seysara | Sarecycline | Sarecycline | Sarecycline | 10/1/2018 |
2018 | 41 | Libtayo | Cemiplimab-rwlc | Cemiplimab-rwlc | Cemiplimab-rwlc | 9/28/2018 |
2018 | 40 | Vizimpro | Dacomitinib | Dacomitinib | Dacomitinib | 9/27/2018 |
2018 | 39 | Emgality | Galcanezumab-gnlm | Galcanezumab-gnlm | Galcanezumab-gnlm | 9/27/2018 |
2018 | 38 | Copiktra | Duvelisib | Duvelisib | Duvelisib | 9/24/2018 |
2018 | 37 | Ajovy | Fremanezumab-vfrm | Fremanezumab-vfrm | Fremanezumab-vfrm | 9/14/2018 |
2018 | 36 | Lumoxiti | Moxetumomab pasudotox-tdfk | Moxetumomab pasudotox-tdfk | Moxetumomab pasudotox-tdfk | 9/13/2018 |
2018 | 35 | Pifeltro | Doravirine | Doravirine | Doravirine | 8/30/2018 |
2018 | 34 | Xerava | Eravacycline | Eravacycline | Eravacycline | 8/27/2018 |
2018 | 33 | Takhzyro | Lanadelumab | Lanadelumab | Lanadelumab | 8/23/2018 |
2018 | 32 | Oxervate | Cenegermin-bkbj | Cenegermin-bkbj | Cenegermin-bkbj | 8/22/2018 |
2018 | 31 | Diacomit | Stiripentol | Stiripentol | Stiripentol | 8/20/2018 |
2018 | 30 | Galafold | Migalastat | Migalastat | Migalastat | 8/10/2018 |
2018 | 29 | Annovera | Segesterone acetate and ethinyl estradiol vaginal system | Segesterone acetate and ethinyl estradiol vaginal system | Segesterone acetate and ethinyl estradiol vaginal system | 8/10/2018 |
2018 | 28 | Onpattro | Patisiran | Patisiran | Patisiran | 8/10/2018 |
2018 | 27 | Poteligeo | Mogamulizumab-kpkc | Mogamulizumab-kpkc | Mogamulizumab-kpkc | 8/8/2018 |
2018 | 26 | Mulpleta | Lusutrombopag | Lusutrombopag | Lusutrombopag | 7/31/2018 |
2018 | 25 | Omegaven | Fish oil triglycerides | Fish oil triglycerides | Fish oil triglycerides | 7/27/2018 |
2018 | 24 | Orilissa | Elagolix sodium | Elagolix sodium | Elagolix sodium | 7/23/2018 |
2018 | 23 | Krintafel | Tafenoquine | Tafenoquine | Tafenoquine | 7/20/2018 |
2018 | 22 | Tibsovo | Ivosidenib | Ivosidenib | Ivosidenib | 7/20/2018 |
2018 | 21 | TPOXX | Tecovirimat | Tecovirimat | Tecovirimat | 7/13/2018 |
2018 | 20 | Braftovi | Encorafenib | Encorafenib | Encorafenib | 6/27/2018 |
2018 | 19 | Mektovi | Binimetinib | Binimetinib | Binimetinib | 6/27/2018 |
2018 | 18 | Zemdri | Plazomicin | Plazomicin | Plazomicin | 6/25/2018 |
2018 | 17 | Epidioloex | Cannabidiol | Cannabidiol | Cannabidiol | 6/25/2018 |
2018 | 16 | Moxidectin | Moxidectin | Moxidectin | Moxidectin | 6/13/2018 |
2018 | 15 | Olumiant | Baricitinib | Baricitinib | Baricitinib | 5/31/2018 |
2018 | 14 | Palynziq | Pegvaliase-pqpz | Pegvaliase-pqpz | Pegvaliase-pqpz | 5/24/2018 |
2018 | 13 | Doptelet | Avatrombopag | Avatrombopag | Avatrombopag | 5/21/2018 |
2018 | 12 | Lokelma | Sodium zirconium cyclosilicate | Sodium zirconium cyclosilicate | Sodium zirconium cyclosilicate | 5/18/2018 |
2018 | 11 | Aimovig | Erenumab-aooe | Erenumab-aooe | Erenumab-aooe | 5/17/2018 |
2018 | 10 | Lucemyra | Lofexidine hydrochloride | Lofexidine hydrochloride | Lofexidine hydrochloride | 5/16/2018 |
2018 | 9 | Akynzeo | Fosnetupitant and palonosetron | Fosnetupitant and palonosetron | Fosnetupitant and palonosetron | 4/19/2018 |
2018 | 8 | Crysvita | Burosumab-twza | Burosumab-twza | Burosumab-twza | 4/17/2018 |
2018 | 7 | Tavalisse | Fostamatinib | Fostamatinib | Fostamatinib | 4/17/2018 |
2018 | 6 | Ilumya | Tildrakizumab | Tildrakizumab | Tildrakizumab | 3/20/2018 |
2018 | 5 | Trogarzo | Ibalizumab-uiyk | Ibalizumab-uiyk | Ibalizumab-uiyk | 3/6/2018 |
2018 | 4 | Erleada | Apalutamide | Apalutamide | Apalutamide | 2/14/2018 |
2018 | 3 | Symdeko | Tezacaftor; ivacaftor | Tezacaftor; ivacaftor | Tezacaftor; ivacaftor | 2/12/2018 |
2018 | 2 | Biktarvy | Bictegravir, embitcitabine, tenofovir alafenamide | Bictegravir, embitcitabine, tenofovir alafenamide | Bictegravir, embitcitabine, tenofovir alafenamide | 2/7/2018 |
2018 | 1 | Lutathera | Lutetium lu 177 dotatate | Lutetium lu 177 dotatate | Lutetium lu 177 dotatate | 1/26/2018 |